Trump threatens 100% tariff on pharma products next week for companies not building in USnews2025-09-26T01:17:24+00:00September 26th, 2025|Endpoints News|
White House weighs broad drug pricing announcementnews2025-09-25T21:10:12+00:00September 25th, 2025|Endpoints News|
Two new ARPA-H programs aim to boost genetic medicine accessnews2025-09-25T20:32:40+00:00September 25th, 2025|Endpoints News|
FDA approves Lilly’s oral SERD in second-line breast cancernews2025-09-25T19:23:52+00:00September 25th, 2025|Endpoints News|
Novartis escalates court fight against Maine 340B law news2025-09-25T19:02:51+00:00September 25th, 2025|Endpoints News|
Post Hoc Live: How the US can compete with China biotech, with Scott Gottliebnews2025-09-25T18:51:41+00:00September 25th, 2025|Endpoints News|
Biogen calls it quits on AAV gene therapy, againnews2025-09-25T18:33:19+00:00September 25th, 2025|Endpoints News|
Kardigan gets the rights to a MyoKardia drug; Lilly stops Phase 2 trial for muscle-sparing candidatenews2025-09-25T15:29:36+00:00September 25th, 2025|Endpoints News|
Virtual team of researchers, advocates try to break 40-year logjam in osteosarcomanews2025-09-25T15:15:19+00:00September 25th, 2025|Endpoints News|
Catalent moves into new HQ; Fujifilm opens factory in North Carolinanews2025-09-25T15:10:57+00:00September 25th, 2025|Endpoints News|
